Showing results (161-170 of 236) with videos related to

Sort By:
Pageof 24
Arthritis Care & Research|November 12, 2015
Safety of Abatacept in Rheumatoid Arthritis With Serologic Evidence of Past or Present Hepatitis B Virus InfectionMelissa Padovan, Matteo Filippini, Angela Tincani, et al.
AIDS Reviews|November 24, 2005
Antiretroviral therapy in chronic liver disease: focus on HIV/HCV coinfection--statements of the First Italian Consensus WorkshopGiampiero Carosi, Massimo Puoti, Giovanni Antonucci, et al.
Microorganisms|January 23, 2024
High-Risk Neutropenic Fever and Invasive Fungal Diseases in Patients with Hematological MalignanciesGiovanni Mori, Sara Diotallevi, Francesca Farina, et al.
JMIR Public Health and Surveillance|September 20, 2021
Algorithm for Individual Prediction of COVID-19-Related Hospitalization Based on Symptoms: Development and Implementation StudyRossella Murtas, Nuccia Morici, Chiara Cogliati, et al.
Infectious Diseases and Therapy|January 21, 2025
Predictors of COVID-19 Readmission Among Patients Previously Hospitalized for SARS-CoV-2Marta Colaneri, Marta Canuti, Ginevra Torrigiani, et al.
Expert Review of Anti-Infective Therapy|August 17, 2020
Efficacy and safety of dalbavancin in the treatment of acute bacterial skin and skin structure infections (ABSSSIs) and other infections in a real-life setting: data from an Italian observational multicentric study (DALBITA study)Francesca Bai, Chiara Aldieri, AnnaMaria Cattelan, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 15, 2023
Determinants of worse liver-related outcome according to HDV infection among HBsAg positive persons living with HIV: Data from the ICONA cohortAntonella d'Arminio Monforte, Alessandro Tavelli, Romina Salpini, et al.
BMC Infectious Diseases|February 18, 2021
SARS-CoV-2 RNA in plasma samples of COVID-19 affected individuals: a cross-sectional proof-of-concept studyLuna Colagrossi, Maria Antonello, Silvia Renica, et al.
Infection|May 30, 2018
Safety and efficacy of ombitasvir/paritaprevir/ritonavir/dasabuvir plus ribavirin in patients over 65 years with HCV genotype 1 cirrhosisAntonio Ascione, Massimo De Luca, Mario Melazzini, et al.
Journal of Clinical Medicine|December 2, 2020
The Burden of Clostridioides Difficile Infection during the COVID-19 Pandemic: A Retrospective Case-Control Study in Italian Hospitals (CloVid)Guido Granata, Alessandro Bartoloni, Mauro Codeluppi, et al.
Pageof 24